Literature DB >> 9186337

Transrectal ultrasound appearance of prostatic granulomas secondary to bacillus Calmette-Guerin instillation.

M K Terris1, M Macy, F S Freiha.   

Abstract

PURPOSE: To our knowledge the transrectal ultrasound appearance of prostatic granulomas occurring after intravesical bacillus Calmette-Guerin (BCG) therapy has not been thoroughly described.
MATERIALS AND METHODS: A total of 13 men with a history of transitional cell carcinoma of the bladder treated with intravesical BCG underwent transrectal ultrasound followed by prostate biopsy and/or cystoprostatectomy.
RESULTS: Of the 13 patients studied 9 (69.2%) had intensely hypoechoic lesions anteriorly in the transition zone of the prostate on ultrasound images. The lesions were histologically proved to be necrotizing granulomas.
CONCLUSIONS: Prostatic granulomas secondary to BCG instillation appear as distinct, intensely hypoechoic anterior lesions within the transition zone of the prostate. Prostatic adenocarcinoma arising in the transition zone is usually not visible and would not be easily confused with granulomas. However, since transitional cell carcinoma involving the prostate can appear hypoechoic in the transition zone, transrectal or transurethral tissue sampling may be indicated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186337     DOI: 10.1097/00005392-199707000-00038

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical Bacillus Calmette-Guerin therapy.

Authors:  Jennifer K Logan; Annerleim Walton-Diaz; Soroush Rais-Bahrami; Maria J Merino; Baris Turkbey; Peter L Choyke; Peter A Pinto
Journal:  J Comput Assist Tomogr       Date:  2014 Mar-Apr       Impact factor: 1.826

2.  Granulomatous Prostatitis After Intravesical Bacillus Calmette-Guérin Instillation Therapy: A Potential Cause of Incidental F-18 FDG Uptake in the Prostate Gland on F-18 FDG PET/CT in Patients with Bladder Cancer.

Authors:  Choon-Young Kim; Sang-Woo Lee; Seock Hwan Choi; Seung Hyun Son; Ji-Hoon Jung; Chang-Hee Lee; Shin Young Jeong; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Nucl Med Mol Imaging       Date:  2015-09-11

Review 3.  Plant Bioactives and the Prevention of Prostate Cancer: Evidence from Human Studies.

Authors:  Tracey L Livingstone; Gemma Beasy; Robert D Mills; Jenny Plumb; Paul W Needs; Richard Mithen; Maria H Traka
Journal:  Nutrients       Date:  2019-09-18       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.